Fidelity National Financial trades at a 30% discount to intrinsic value, despite transforming into a diversified financial services platform. FNF’s forward P/E of 8.7–10.4x and 4% dividend yield offer ...

Fidelity Investments is launching its first stablecoin, the Fidelity Digital Dollar (FIDD), in early February, marking a major move by one of the largest traditional financial institutions into ...

Fidelity will issue a stablecoin through its newly approved national trust bank, signaling deeper institutional use of blockchain-based payment infrastructure. Fidelity Investments plans to launch a ...

The MDAC team will be collecting bottled water, nonperishable food items such as soup and other canned goods, can openers and basic essential paper products to be delivered to North Mississippi as ...

Fidelity National Information Services' stock has had a rough past few years. The stock price plummeted to a 52-week low this week. It has some positive momentum, but is it enough to warrant a buy?

FDVV offers a higher dividend yield and a slightly better one-year return than VIG. VIG charges a lower expense ratio and holds 338 stocks, with much greater assets under management. Both ETFs lean ...

JACKSONVILLE, Fla. and DES MOINES, Iowa, Dec. 18, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE: FNF) ("FNF"), a leading provider of title insurance and transaction services to the real ...

Five digital asset firms have received conditional approvals Friday to become federally chartered trust banks by the Office of the Comptroller of Currency (OCC) in a major step to bring U.S. dollar ...

The OCC has conditionally approved five crypto firms — Ripple, Circle, Fidelity Digital Assets, BitGo, and Paxos — to become national trust banks, advancing the integration of digital assets into U.S.

In 2026, Americans will get free admission to national parks on President Donald Trump's birthday but no longer on Juneteenth and Martin Luther King Jr. Day, according to the National Park Service ...

CLN-049 has received FDA fast track designation for relapsed or refractory AML, highlighting its potential as a novel immunotherapy option. Initial phase 1 study results demonstrate meaningful ...